Defect Bash - Literature Review
Defect bash is a co-located testing session performed by a group of people. We performed a systematic review of the academic and grey literature, i.e. informally published writings, of the defect bash. Altogether, we found 44 items (17 academic and 27 grey literature sources) that were identified useful for the review. Based on the review the definition of defect bash is presented, benefits and limitations of using defect bash are given. Finally, the process of doing defect bash is outlined. This review provides initial understanding on how defect bash could be useful in achieving the software quality and lays foundation for further academic studies of this topic.
Team Exploratory Testing Sessions
Exploratory testing (ET) is popular, especially among agile development teams. In this paper, we study the team aspect in the ET context and explore how to use ET in team sessions to complement other testing activities. The goal was to define a team exploratory testing (TET) session approach and to provide evidence that the approach is worth using. A TET session approach is defined by means of parameters, roles, and process. Also, instructions for using the approach are given. The team is the key factor that gives the approach its value and distinguishes it from basic ET. The team enables greater access to expertise, experience, and information. The TET session approach enables participants with different professional background to join in the session. The sessions may be focused on different purposes; they can contribute to finding defects or learning the system, for example. With careful parameter definition, the approach’s risks are mitigated.
Multiple-dose pharmacokinetics of moxisylyte after oral administration to healthy volunteers.
The pharmacokinetics of moxisylyte in plasma and urine was investigated after oral administration. Twelve subjects were treated orally, twice daily with 240 mg of the drug for 6 days; on day 7, the subjects received a last dose of 240 mg of moxisylyte. Moxisylyte was assayed in plasma and urine by a specific HPLC method with fluorimetric detection. Moxisylyte was absorbed rapidly and changed to its metabolites immediately after drug administration; unchanged moxisylyte was not found in plasma. Two metabolites were found in plasma and urine: conjugated desacetylmoxisylyte (DAM) and the conjugate of desmethylated DAM (MDAM). The pharmacokinetic parameters determined after the first oral administration were not modified on multiple dosing. The apparent elimination half-lives of conjugated DAM and MDAM were 2.3 and 3.5 h, respectively. Elimination of these two metabolites in urine averaged 50 and 10%, respectively.